| LLY Technical Analysis Data | ||||||||||||||||
Also see: |
47.44| LLY Current Stock Quote |
Quotes delayed 20 minutes  Free LLY Email Alerts:
Get Dividend Alerts 
Get SEC Filing Alerts
|
| LLY Stock Price Chart |
| LLY Technical Analysis Charts |
  |
|
|
| About Lilly (Eli) & Co |
| Eli Lilly and Co. is a medicine company. Co. discovers, develops, manufactures and markets products in the human pharmaceutical products segment. Its diabetes, obesity and other cardiometabolic products include Basaglar, Humalog, Mounjaro, Trulicity and Zepbound. Its oncology products include Alimta, Retevmo, Tyvyt and Verzenio. Its immunology products include Ebglyss, Olumiant, Omvoh and Taltz. Its neuroscience products include Cymbalta and Emgality. Its other products and therapies include Cialis and Forteo. It manufactures and distributes its products through facilities in the U.S. (U.S.), including Puerto Rico, and in Europe and Asia. When researching a stock like Eli Lilly, many investors are the most familiar with Fundamental Analysis — looking at a company's balance sheet, earnings, revenues, and what's happening in that company's underlying business. Investors who use Fundamental Analysis to identify good stocks to buy or sell can also benefit from LLY Technical Analysis to help find a good entry or exit point. Technical Analysis is blind to the fundamentals and looks only at the trading data for LLY stock — the real life supply and demand for the stock over time — and examines that data in different ways. |
| LLY Technical Analysis Charts |
  |
| Video: Technical Analysis | |
|
Video: Technical Analysis
| LLY Technical Analysis Peers |
| Eli Lilly (LLY) is categorized under the Healthcare sector; to help you further research Technical Analysis, below are some other companies in the same sector:
MCK Technical Analysis MDT Technical Analysis MMM Technical Analysis MRK Technical Analysis MRNA Technical Analysis PFE Technical Analysis PODD Technical Analysis Q Technical Analysis REGN Technical Analysis RMD Technical Analysis More Healthcare companies » |
Eli Lilly Technical Analysis | www.TechnicalAnalysisChannel.com | Copyright © 2019 - 2026, All Rights Reserved
Nothing in TechnicalAnalysisChannel.com is intended to be investment advice, nor does it represent the opinion of, counsel
from, or recommendations by BNK Invest Inc. or any of its affiliates, subsidiaries or partners.
None of the information contained herein constitutes a recommendation that any particular security, portfolio,
transaction, or investment strategy is suitable for any specific person. All viewers agree that under no
circumstances will BNK Invest, Inc,. its subsidiaries, partners, officers, employees, affiliates, or agents be held
liable for any loss or damage caused by your reliance on information obtained. By visiting, using or viewing this site, you
agree to the following Full Disclaimer & Terms of Use and
Privacy Policy. Video widget and market videos powered by Market News Video. Quote and option data delayed at
least 15 minutes; stock quote data powered by Ticker Technologies, and Mergent.